Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

259
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
259
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

156
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
156
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

751
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
751
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins.

Nature communications·2026
Same author

Riemannian denoising model for molecular structure optimization with chemical accuracy.

Nature computational science·2026
Same author

Engineering Excited States of Pt-Based Deep-Blue Phosphors to Enhance OLED Stability.

ACS omega·2025
Same author

MetalloGen: Automated 3D Conformer Generation for Diverse Coordination Complexes.

Journal of chemical information and modeling·2025
Same author

Machine-Learning-Based Design of Metallocene Catalysts for Controlled Olefin Copolymerization.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Facilitating Transition State Search with Minimal Conformational Sampling Using Reaction Graph.

Journal of chemical theory and computation·2025
Same journal

Learning Moisture-Induced Damage From Vision: Diffusion Models for Real-Time Monitoring of Additive Manufacturing Processes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Intrinsic Dual-Phase Regulated GeSe<sub>2</sub> Nanoparticles Triggered by Ball-Milling Treatment for Photonic Multi-Valued Logic Circuits.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Plant Photoregulator-Inspired S-Type Heterojunction System for Diabetic Keratopathy via Tri-Modal Light-Driven Immunometabolic Reprogramming, Tissue Repair, and Antibacterial Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

eEF1G Orchestrates Translation to Ensure Meiotic Progression in Transcriptionally Quiescent Spermatocytes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Ultrasound-Recharged Sub-Nanometer Palladium Catalysts for on-Demand and Self-Terminating Bioorthogonal Prodrug Activation in Cancer Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Graphene Aerogels With Spherical Pore Structure for Broad Frequency Regulation and Enhanced Low-Frequency Response.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
查看所有相关文章

相关实验视频

Updated: Sep 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542

BInD:用于基于多目标结构的药物设计的结合和相互作用生成扩散模型.

Joongwon Lee1, Wonho Zhung1, Jisu Seo1

  • 1Department of Chemistry, KAIST, Yuseong-gu, Daejeon, 34141, Republic of Korea.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 11, 2025
PubMed
概括
此摘要是机器生成的。

一个新的扩散模型,BInD,共同生成分子及其蛋白质相互作用以进行基于结构的药物设计 (SBDD). 这种方法平衡了分子特性和目标特异性,优于现有方法.

关键词:
3D分子生成模型 3D分子生成模型扩散模型的扩散模型.非共价相互作用的非共价相互作用基于结构的药物设计.

更多相关视频

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

相关实验视频

Last Updated: Sep 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

科学领域:

  • 计算化学是一种计算化学.
  • 结构生物学是结构生物学.
  • 人工智能在药物发现中的作用

背景情况:

  • 几何深度生成模型和结构数据的进步使基于结构的药物设计 (SBDD) 能够仅使用目标蛋白信息.
  • 现有的模型往往难以平衡多个目标,导致特定任务的性能不足.

研究的目的:

  • 介绍BInD,一种新型的扩散模型,旨在共同生成分子及其与标蛋白的相互作用.
  • 解决现有模型在平衡SBDD多个目标方面的局限性.
  • 通过分子设计和优化来增强目标结合和特异性.

主要方法:

  • 开发BInD,一个扩散模型,包含基于知识的指导,用于共产.
  • 确保对特定目标相互作用,分子性质和局部几何学的平衡考虑.
  • 实施一个NCI驱动的分子设计和优化策略.

主要成果:

  • 在所有关键目标上,BInD表现强,与最先进的方法相匹配或超越.
  • 该模型成功地联合生成了具有平衡性质和目标相互作用的分子.
  • 提议的优化方法提高了目标的约束性和特异性.

结论:

  • 通过共同生成分子及其相互作用,BInD为SBDD提供了一个平衡的方法.
  • 该模型代表了药物发现的生成模型的重大进展.
  • 由NCI驱动的优化进一步完善了分子设计,以提高治疗潜力.